Ohio Sleep Medicine Institute is now offering Inspire therapy, a new clinically proven treatment approved by the FDA, for patients with Obstructive Sleep Apnea (OSA). Our doctors and staff can help determine if you are a good candidate for this treatment option.
Introducing Inspire Therapy
• Clinically proven to reduce sleep apnea events and improve quality of life and daytime functioning
• Fully implanted; does not require a mask or oral appliance
• Designed to work with the body's natural anatomy and breathing processes
• Approved by the FDA
How does it work?
Patients in Central Ohio and beyond can now benefit from Inspire, a new sleep apnea treatment based on upper airway stimulation. Developed by Inspire Medical, this small device is implanted under the skin near the right collar bone and activated at bedtime by the patient via a handheld remote. Inspire consists of a small battery attached to a breathing sensor lead and a stimulation lead. The system stimulates the hypoglossal nerve, which in turn, activates key airway muscles during breathing to keep the airway open during sleep.
Inspire provides an alternative treatment to CPAP, oral appliances, and other forms of therapy. It allows patients to move freely in their bed without any mask on their face or appliance in their mouth. The treatment requires an upper airway screening endoscopy, followed by an outpatient procedure performed by a specially trained ENT physician. Patients are monitored post surgery by a sleep medicine physician who refines the optimal amplitude of the stimulation signal in relation to ventilatory efforts during sleep.
Inspire clinical efficacy results
Results from a study evaluating the clinical safety and effectiveness of this new therapy show a significant reduction in sleep apnea severity and snoring after implantation of the Inspire device. During sleep, participants experienced a 68% reduction in the number of apnea or hypopnea events per hour and a 70% reduction in the number of times blood oxygen level dropped per hour. Moreover, 85% of bed partners also reported no or soft snoring.
Overall quality of life considerably improved. Participants observed a significant increase in alertness and scored within a normal range on the Epworth Sleepiness Scale. Results from the Functional Outcomes of Sleep Questionnaire also showed normalized daytime functioning and daytime sleepiness level.
Who can benefit from Inspire?
Inspire is specifically designed for people with moderate to severe OSA who are unable to use Continuous Positive Airway Pressure (CPAP) therapy. It is recommended for patients 22 years of age or older who are free of pronounced anatomical abnormalities.